A Liver-Targeted Copper Supplement Reduces Metabolic Dysfunction-Associated Liver Steatosis by Increasing Lipolysis and Fatty Acid Oxidation
Jaehee Kim, Vanha N. Pham, Timothy A. Su, Irene Liparulo, Diyala S. Shihadih, Tong Xiao, Xiao Xie, Yuichi Aki, Aidan T. Pezacki, Wendy Cao, James A. Olzmann, Joshua D. Rabinowitz, Andreas Stahl, Christopher J. Chang
The paper shows liver-targeted copper supplementation reduces steatosis by enhancing lipolysis and fatty acid oxidation through copper-dependent metabolic pathways.
bioRxiv · May 20, 2026 · PreprintPhysiology